Screener
Roivant Sciences ROIV Accrued Research And Development Expenses Current
Accrued Research And Development Expenses Current at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept roiv:AccruedResearchAndDevelopmentExpensesCurrent.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
FAQ
- What is Roivant Sciences's accrued research and development expenses current?
- Roivant Sciences (ROIV) reported accrued research and development expenses current of $113.44M in Q2 2026.
- How has Roivant Sciences's accrued research and development expenses current changed year-over-year?
- Roivant Sciences's accrued research and development expenses current increased by 127.8% year-over-year, from $49.8M to $113.44M.
- What is the long-term trend for Roivant Sciences's accrued research and development expenses current?
- Over 4 years (2021 to 2025), Roivant Sciences's accrued research and development expenses current has grown at a 8.8% compound annual growth rate (CAGR), from $66.19M to $92.75M.
- What does accrued research and development expenses current mean?
- Accrued Research And Development Expenses Current as reported by Roivant Sciences Ltd. Common Shares.
Ask your AI about Roivant Sciences's accrued research and development expenses current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude